Free Trial
OTCMKTS:TAIPY

Taisho Pharmaceutical (TAIPY) Stock Price, News & Analysis

$12.00
0.00 (0.00%)
(As of 06/11/2024 ET)
Today's Range
$12.00
$12.00
50-Day Range
$12.00
$14.54
52-Week Range
$8.88
$15.52
Volume
N/A
Average Volume
2,085 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TAIPY stock logo

About Taisho Pharmaceutical Stock (OTCMKTS:TAIPY)

Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The company offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the Colac series of laxative products; the Naron series and other products for antipyretic analgesics; the Preser series of hemorrhoid treatment products; Hapacol, Efferalgan, Dafalgan, and Tempra for antipyretic analgesics; Counterpain topical anti-inflammatory analgesics; Vitacilina, a dermatological treatment product; and VICKS, a cough suppressant throat lozenges and medicated drops. Further it provides Clarith, a macrolide antibiotic; Bonviva, a bisphosphonate osteoporosis agent; Lusefi, a type 2 diabetes mellitus agent; and LOQOA, a transdermal anti-inflammatory analgesic. The company also offers raw materials for pharmaceuticals and quasi-drugs; and supplies health foods and skin care products, as well as engages in real estate leasing, management, possession, and operation. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is based in Tokyo, Japan.

TAIPY Stock Price History

TAIPY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive TAIPY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Taisho Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:TAIPY
Fax
N/A
Employees
8,784
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Akira Uehara (Age 83)
    CEO & Representative Director
    Comp: $727.72k
  • Mr. Shigeru Uehara
    Executive VP & Director
  • Shinichi Tanaka
    General Manager of Corporate Communications
  • Mr. Ken Uehara
    MD & Executive Director
  • Mr. Tetsu Watanabe
    Executive Director
  • Mr. Jun Kuroda (Age 66)
    Executive VP & Director

TAIPY Stock Analysis - Frequently Asked Questions

How have TAIPY shares performed in 2024?

Taisho Pharmaceutical's stock was trading at $14.81 on January 1st, 2024. Since then, TAIPY shares have decreased by 19.0% and is now trading at $12.00.
View the best growth stocks for 2024 here
.

How do I buy shares of Taisho Pharmaceutical?

Shares of TAIPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TAIPY) was last updated on 6/12/2024 by MarketBeat.com Staff

From Our Partners